Can We Treat Colorectal Cancer With Immunotherapy?
March is Colorectal Cancer Awareness Month. About 134,490 people are estimated to be diagnosed with and about 49,190 are...
March is Colorectal Cancer Awareness Month. About 134,490 people are estimated to be diagnosed with and about 49,190 are...
An emerging hallmark of cancer cells is their ability to hide from the body’s immune system. The human immune...
The number of anticancer immunotherapeutics approved by the U.S. Food and Drug Administration (FDA) is rising rapidly. In fact,...
This post explores the challenges we face with anti-EGFR monoclonal antibody therapies and new strategies researchers have developed to...
Currently, anti-EGFR therapies are approved by the U.S. Food and Drug Administration for the treatment of non-small cell lung...
AACR membership includes scientists and physicians from across the cancer research enterprise. Whether basic, translational, or clinical researchers, they...
Over the years, clinical research has become an integral part of the American Association for Cancer Research’s meetings and...
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
In a study published Tuesday in the American Association for Cancer Research’s journal Clinical Cancer Research, researchers identified two...
Two papers in the journals of the American Association for Cancer Research this morning provide new information on tamoxifen,...